두경부 종양에서 TIG1 유전자의 Hypermethylation = Hypermethylation of TIG1 in Head and Neck Cancer

다국어 초록 (Multilingual Abstract)

Background and Objectives：Decreased expression and growth suppression of Tazarotene-Induced Gene 1 (TIG1) were reported in prostate cancer. In this study, we examined the possibility of TIG1 transcriptional silencing by hypermethylation in head and neck cancer. Subjects and Method：We extracted DNA and total RNA from five head and neck cell lines (O11, O12, O19, O22 and O28), and three prostate cell lines (PC3, LNCap and DU145). We checked the methylation status of TIG1 by methylation-specific PCR (MSP) and RT-PCR. We also examined primary cancer tissues of 32 head and neck cancer, 31 prostate cancer and 10 normal samples. Results：We found that all of five head and neck (100%) cell lines and two of three prostate (66.7%) cell lines were methylated. RT-PCR analysis confirmed the absence of TIG1 expression in six cell lines with methylation. We checked primary cancer by MSP and found TIG1 methylation in 16 of 32 (50%) head and neck cancers, and 17 of 31 (54.8%) prostate cancers. Normal head and neck and prostate tissues were free of methylation. Conclusion：Our results support the notion that methylation might be an important mechanism of TIG1 inactivation and a target event in head and neck cancer. (Korean J Otolaryngol 2005;48:247-52)

참고문헌 (Reference)

• 1 Patel S, "a novel retinoic acid receptor-responsive gene in skin" 269-74, 1996
• 2 Magewu AN, "Ubiquitous and tenacious methylation of theCpG site in codon 248 of the p53 gene may explain its frequent appearanceas a mutational hot spot in human cancer" 14 : 4225-32, Biol1994
• 3 Maestro R, "Three discrete regions of deletion at 3p in head andneck cancers" 53 : 5775-9, 1993
• 4 Bird A, "The essentials of DNA methylation" 70 : 5-8, 1992
• 5 Kuzmin I, "The RASSF1A tumor suppressor gene is inactivatedin prostate tumors and suppresses growth of prostate carcinoma cells" 62 : 3498-502, 2002
• 6 Lerman MI, "The 630-kb lung cancer homozygous deletionregion on human chromosome 3p21" Cancer Res 6116-33,
• 7 Jing C, "Tazarotene-induced gene 1(TIG1)expression in prostate carcinomasand its relationship to tumorigenicity" 94 : 482-90, Inst2002
• 8 Li E, "Targeted mutation of the DNA methyltransferasegene results in embryonic lethality" 69 : 915-26, 1992
• 9 Hollstein M, "Somatic muations in the p53 gene of human tumor andcell lines:Updated compilation" 24 : 141-6, 1996
• 10 Li E, "Role for DNA methylation in genomicimprinting" 366 : 362-5, 1993
• 11 Panning B, "RNA and the epigenetic regulation of Xchromosome inactivation" 93 : 305-8, 1998
• 12 Rosas SL, "Promoter hypermethylation patterns of 16,O6-methylguanine-DNA-methyltrans ferase,and death-associated proteinkinase in tumors and saliva of head and neck cancer patients" 61 : 939-42, 2001
• 13 Denissenko MF, "Preferential formationof benzo[a]pyrene adducts at lung cancer mutational hot spots in p53" 274 : 430-2, 1996
• 14 Care TE, "Nonrandom chromosomeaberrations and clonal populations in head and neck cancer" 13 : 2561-7, 1993
• 15 Greenblatt MS, "Mutations inthe p53 tumor suppressor gene:Clues to cancer biology and molecularcarcinogeneis" 54 : 4855-78, 1994
• 16 Herman JG, "Methylation-specific PCR:A novel PCR assay for methylation status ofCpG islands" 93 : 9821-6, 1996
• 17 Agathanggelou A, "Methylation associated inactivation of RASSF1A fromregion 3p21 3 in lung" ho (ho): 1509-18, 2001
• 18 Li LC, "Methylation" 705-9, 2001
• 19 Herman JG, "Incidence and functional consequences of hMLH1 promote hypermethylationin colorectal cancer" 95 : 6870-5, 1998
• 20 Lee DJ, "Impact of chromosome 14q loss on survival in primary head and necksquamous cell carcinoma" Clin Cancer Res 3 : 501-5, 1997
• 21 Gonzalgo ML, "Identification and characterization of differentially methylatedregions of genomic DNA by methylation-sensitive arbitrarilyprimed PCR" 57 : 594-9, 1997
• 22 Woodson K, "Hypermethylationof GSTP1,CD44 and E-cadherin genes in prostate canceramong US blacks and whites" 55 : 199-205, 2003
• 23 Lo KW, "Highfrequency of promoter hypermethylation of RASSF1A in nasopharyngealcarcinoma" 61 : 3877-81, 2001
• 24 Sanchez-Cespedes M, "Gene promoter hypermethylation in tumors andserum of head and neck cancer patients" 60 : 892-5, 2000
• 25 van der Riet P, "Frequent loss of chromosome 9p21-22 early in head and neckcancer progression" 54 : 1156-8, 1994
• 26 Waber PG, "Frequent allelic loss at chromosomearm 3p is distinct from genetic alterations of the Von-Hippel Lindautumor suppressor gene in head and neck cancer" 12 : 365-9, 1996
• 27 Spafford MF, "Detection of head and neck squamous cell carcinoma amongexfoliated oral mucosal cells by microsatellite analysis" ClinCancer Res 7 : 607-12, 2001
• 28 Jones PA, "DNA methylation errors and cancer" 56 : 2463-67, 1996
• 29 Wei MH, "Construction of a 600-kilobase cosmid clone contig and generationof a transcriptional map surrounding the lung cancer tumor suppressorgene locus on human chromosome 3p 21 Progresstoward the isolation of a lung cancer TSG" Cancer Res 1487-92, 1996
• 30 Greenlee RT, "Cancer statistics2001" 51 : 15-36, 2001
• 31 Baylin SB, "Alterationsin DNA methylation a fundamental aspect of neoplasia" 72 : 141-96, 1998
• 32 Rideout WM3rd, "5-methylcytosineas an endogenous mutagen in the human LDL receptor and p53genes" 249 : 1288-90, 1990